JIC
Johnson Investment Counsel Portfolio holdings
AUM
$11.1B
1-Year Return
15.75%
This Quarter Return
+4.85%
1 Year Return
+15.75%
3 Year Return
+60.71%
5 Year Return
+113.42%
10 Year Return
+242.02%
AUM
$7.53B
AUM Growth
+$205M
(+2.8%)
Cap. Flow
-$66.3M
Cap. Flow
% of AUM
-0.88%
Top 10 Holdings %
Top 10 Hldgs %
30.77%
Holding
692
New
33
Increased
208
Reduced
302
Closed
32
Top Buys
| 1 |
Cencora
COR
|
$58.3M |
| 2 |
American Financial Group
AFG
|
$43.9M |
| 3 |
Nasdaq
NDAQ
|
$23.4M |
| 4 |
UnitedHealth
UNH
|
$15.7M |
| 5 |
Chevron
CVX
|
$15.5M |
Top Sells
| 1 |
M&T Bank
MTB
|
$32.9M |
| 2 |
PPG Industries
PPG
|
$30.3M |
| 3 |
Nike
NKE
|
$27.1M |
| 4 |
Analog Devices
ADI
|
$25.1M |
| 5 |
First Horizon
FHN
|
$22.7M |
Sector Composition
| 1 | Technology | 14.84% |
| 2 | Financials | 14.02% |
| 3 | Healthcare | 10.69% |
| 4 | Consumer Staples | 10.55% |
| 5 | Industrials | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Woodside Energy
WDS
$31.6B
| $207K | ﹤0.01% |
9,235
| – | – |
|
627
Old Dominion Freight Line
ODFL
$31.7B
| $207K | ﹤0.01% |
+1,214
| New | +$207K |
|
628
Ingersoll Rand
IR
$32.2B
| $205K | ﹤0.01% |
+3,524
| New | +$205K |
|
629
Eastman Chemical
EMN
$7.93B
| $205K | ﹤0.01% |
2,430
-3,537
| -59% | -$298K |
|
630
ORIX
IX
$29.3B
| $204K | ﹤0.01% |
12,425
| – | – |
|
631
MarketAxess Holdings
MKTX
$7.01B
| $203K | ﹤0.01% |
+520
| New | +$203K |
|
632
Vanguard ESG US Stock ETF
ESGV
$11.2B
| $203K | ﹤0.01% |
+2,830
| New | +$203K |
|
633
iShares Semiconductor ETF
SOXX
$13.7B
| $201K | ﹤0.01% |
1,359
-546
| -29% | -$80.9K |
|
634
Takeda Pharmaceutical
TAK
$48.6B
| $182K | ﹤0.01% |
11,028
-251
| -2% | -$4.14K |
|
635
Companhia Siderúrgica Nacional
SID
$1.99B
| $175K | ﹤0.01% |
57,100
| – | – |
|
636
Cemex
CX
$13.6B
| $172K | ﹤0.01% |
31,021
| – | – |
|
637
CareCloud
CCLD
$148M
| $168K | ﹤0.01% |
50,000
| – | – |
|
638
Enviri
NVRI
$948M
| $161K | ﹤0.01% |
23,502
| – | – |
|
639
First Commonwealth Financial
FCF
$1.87B
| $160K | ﹤0.01% |
12,889
| – | – |
|
|
CBAY
640
DELISTED
Cymabay Therapeutics
CBAY
| $157K | ﹤0.01% |
18,000
| – | – |
|
641
Viatris
VTRS
$12.2B
| $146K | ﹤0.01% |
15,213
-806
| -5% | -$7.75K |
|
|
PSTX
642
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $144K | ﹤0.01% |
46,758
| – | – |
|
643
Banco Santander
SAN
$141B
| $142K | ﹤0.01% |
38,440
| – | – |
|
644
Root
ROOT
$1.43B
| $136K | ﹤0.01% |
+30,166
| New | +$136K |
|
645
Gerdau
GGB
$6.39B
| $135K | ﹤0.01% |
32,760
| – | – |
|
646
Itaú Unibanco
ITUB
$76.6B
| $121K | ﹤0.01% |
27,280
| – | – |
|
647
Repay Holdings
RPAY
$506M
| $109K | ﹤0.01% |
16,600
| – | – |
|
648
Haleon
HLN
$43.9B
| $106K | ﹤0.01% |
13,006
-1,679
| -11% | -$13.7K |
|
649
Ambev
ABEV
$34.8B
| $81.3K | ﹤0.01% |
28,843
| – | – |
|
650
Gabelli Equity Trust
GAB
$1.89B
| $76K | ﹤0.01% |
13,244
+262
| +2% | +$1.5K |
|